Cargando…
Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis
BACKGROUND: Heart failure (HF) is the end stage of most heart disease. Mesenchymal stem cells (MSCs), with their specific biological effects, have been applied in several clinical trials to evaluate the efficacy in HF therapy. We performed this meta-analysis to review the clinical evidence of their...
Autores principales: | Fan, Mengkang, Huang, Yin, Chen, Zhangwei, Xia, Yan, Chen, Ao, Lu, Danbo, Wu, Yuan, Zhang, Ning, Qian, Juying, Ge, Junbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544951/ https://www.ncbi.nlm.nih.gov/pubmed/31151406 http://dx.doi.org/10.1186/s13287-019-1258-1 |
Ejemplares similares
-
Correction to: Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis
por: Fan, Mengkang, et al.
Publicado: (2019) -
Quantitative Profiling of Serum Carnitines Facilitates the Etiology Diagnosis and Prognosis Prediction in Heart Failure
por: Chen, Zhangwei, et al.
Publicado: (2023) -
Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation
por: Chen, Ao, et al.
Publicado: (2021) -
Association between NLRP3 inflammasome and periprocedural myocardial injury following elective PCI
por: Chen, Ao, et al.
Publicado: (2023) -
Peripheral Artery Tonometry Reveals Impaired Endothelial Function before Percutaneous Coronary Intervention in Patients with Periprocedural Myocardial Injury
por: Chen, Zhangwei, et al.
Publicado: (2021)